Dr. Reddy’s Laboratories Net Worth, Owner, CEO, Head Office

Dr. Reddy’s Laboratories is one of those pharma companies that started out super small in India, but look at it now, it is pretty much global in the generics segment. But it could be, you must have heard of it just recently, and if that’s the case, we’re here to introduce you to this company in a brief way by talking about things like Dr. Reddy’s Laboratories Net Worth, Owner, CEO, Head Office and much more.

Dr. Reddy's Laboratories

Company name Dr. Reddy’s Laboratories Ltd. ​
Establishment year 1984 ​
Head Office Hyderabad
Owner/Founder Founder: Dr. Kallam Anji Reddy
CEO Name Erez Israeli ​
Industry Pharmaceuticals ​
Number of employees 27,811 (as of Mar 31, 2025) ​
Net worth / Market cap ₹996.68 billion (10 Nov 2025) ​
Total revenue (2025) ₹33,741 crore

About The Company

Just to talk about the history stuff first, see, Dr.​‍​‌‍​‍‌​‍​‌‍​‍‌ Reddy’s was founded by Dr. Kallam Anji Reddy with a single aim: to produce good-quality medicines at a price that everyone could afford and make them accessible to all. After a long time, the company transformed from an API (Active Pharmaceutical Ingredients) manufacturer to a branded and generic medicines producer in India. And right now, their main head office is there in Hyderabad.

Net Worth

Clearly and yes, proudly, it continues to be listed on the stock exchange and has a dominant position in India as well as in other major markets. The market capitalization as of November 2025 is around ₹996.68 billion, which just went down to this number from ₹1.0 trillion a few days ago.

Future Outlook & Recent Updates

Next​‍​‌‍​‍‌​‍​‌‍​‍‌ to they have planned a different stage of development, the firm is putting hyper focus on innovation, health products for consumers, and branded businesses rather than just U.S. generics. A major move, one of the key upcoming plans, is the introduction of a generic version of semaglutide (the component in diabetes and weight-loss medicines that is widely used). The release is anticipated in 87 countries in total, as patents expire, with Western markets being the last ones to follow. It is stated by the company that the amount of money that this change can bring in the next years can be super high.

Leave a Reply

Your email address will not be published. Required fields are marked *